Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results